The Summit convened February 21-22, 2008, in Washington, D.C. to bring together experts in epidemiology, pharmacology, toxicology, and addiction treatment in order to build upon the findings of the previous summits in 2003 and 2005. Participants assessed the successes, progress and continued barriers to access to opioid treatment with buprenorphine. Presentations identified best practices and useful clinical supports to enhance the quality of treatment. Participants identified strategies to address emerging issues and concerns. SAMHSA and NIDA will prepare a report on the proceedings.
Expansion of Services for Vermonters in Need of MAT for Opiate Dependence (Todd W. Mandell, M.D.)
Buprenorphine in the Treatment of Opioid Addiction: Balancing Medication Access with Quality Care (Dr. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM)
Buprenorphine: Balancing Access with Quality of Care (Martha Wunsch, M.D.)
Continuing Buprenorphine/Naloxone With Counseling Is More Effective Than Detoxification With Counseling for 15-21 Year Old Opioid Addicts (George Woody, M.D.)
Status Report: Research Needs (Iván Montoya, M.D., M.P.H.)
Special Population Issues (George Woody, M.D.)
Subutex and Suboxone: How Much Is Prescribed vs. Abuse/Diversion Reports (Nabarun Dasgupta, M.P.H.)
Buprenorphine in the Treatment of Opioid Addiction: Balancing Medication Access with Quality Care (Timothy Condon, Ph.D.)
Buprenorphine: Balancing Access with Quality of Care—Opening Remarks (Dr. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM)
Pilot Projects and Unmet Research Needs (Frederick Altice, M.D.)
Education Status Report: Successes & Challenges (John Renner, M.D.)
Buprenorphine and pregnancy: Vermont program development and outcomes (Marjorie Meyer, M.D.)
Emerging Clinical Challenges in Prescribing Buprenorphine (Elinore F. McCance-Katz, M.D., PhD.)
Science-based Treatment of Opioid-Dependent Adolescents: Summary of Research & Research Needs (Lisa Marsch, Ph.D.)
Nurse Care Manager Model (Colleen LaBelle, R.N., A.C.R.N., C.A.R.N.)
Integrating Buprenorphine Into an Abstinence Based, Ambulatory Treatment Program (George Kolodner, M.D.)
Status Report: Research Needs Using Buprenorphine to Treat Opioid Dependence During Pregnancy (Hendrée E. Jones, Ph.D.)
Toward optimal use of buprenorphine and methadone in treatment of heroin dependence (Markus Helig, M.D., Ph.D.)
Speciality Program Buprenorphine Induction: A Viable Means of Improving Diffusion into Office-Based Settings (Erik Gunderson, M.D.)
Physician Clinical Support System (David Fiellin, M.D.)
Drug Enforcement Administration (Denise Curry, J.D.)
Work Group Summaries
|
